1-8 of 8
idh1 gene
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Genomic analysis of primary and secondary myelofibrosis redefines the prognostic impact of ASXL1 mutations: a FIM study

Clinical Trials & Observations
Damien Luque Paz, Jérémie Riou, Emmanuelle Verger, Bruno Cassinat, Aurélie Chauveau, Jean-Christophe Ianotto, Brigitte Dupriez, Françoise Boyer, Maxime Renard, Olivier Mansier, Anne Murati, Jérôme Rey, Gabriel Etienne, Véronique Mansat-De Mas, Suzanne Tavitian, Olivier Nibourel, Stéphane Girault, Yannick Le Bris, François Girodon, Dana Ranta, Jean-Claude Chomel, Pascale Cony-Makhoul, Pierre Sujobert, Margot Robles, Raouf Ben Abdelali, Olivier Kosmider, Laurane Cottin, Lydia Roy, Ivan Sloma, Fabienne Vacheret, Mathieu Wemeau, Pascal Mossuz, Borhane Slama, Vincent Cussac, Guillaume Denis, Anouk Walter-Petrich, Barbara Burroni, Nathalie Jézéquel, Stéphane Giraudier, Eric Lippert, Gérard Socié, Jean-Jacques Kiladjian, Valérie Ugo
Journal: Blood Advances
Blood Adv (2021) 5 (5): 1442–1451.
https://doi.org/10.1182/bloodadvances.2020003444
Published: 2021
Includes: Supplemental data
Journal Articles

Specific patterns of H3K79 methylation influence genetic interaction of oncogenes in AML

Molly C. Kingsley, Hongbo M. Xie, Bo-Rui Chen, Simone S. Riedel, Taylor Pastuer, Madelyn K. Bollig, Tyler Shank, Clara Libbrecht, Sally P. Stabler, Aniruddha J. Deshpande, Andrew M. Intlekofer, Kathrin M. Bernt
Journal: Blood Advances
Blood Adv (2020) 4 (13): 3109–3122.
https://doi.org/10.1182/bloodadvances.2020001922
Published: 2020
Includes: Supplemental data
Journal Articles

Molecular mechanisms mediating relapse following ivosidenib monotherapy in IDH1 -mutant relapsed or refractory AML

Clinical Trials & Observations
Sung Choe, Hongfang Wang, Courtney D. DiNardo, Eytan M. Stein, Stéphane de Botton, Gail J. Roboz, Jessica K. Altman, Alice S. Mims, Justin M. Watts, Daniel A. Pollyea, Amir T. Fathi, Martin S. Tallman, Hagop M. Kantarjian, Richard M. Stone, Lynn Quek, Zenon Konteatis, Lenny Dang, Brandon Nicolay, Parham Nejad, Guowen Liu, Vickie Zhang, Hua Liu, Meredith Goldwasser, Wei Liu, Kevin Marks, Chris Bowden, Scott A. Biller, Eyal C. Attar, Bin Wu
Journal: Blood Advances
Blood Adv (2020) 4 (9): 1894–1905.
https://doi.org/10.1182/bloodadvances.2020001503
Published: 2020
Includes: Supplemental data
Journal Articles

Blast phenotype and comutations in acute myeloid leukemia with mutated NPM1 influence disease biology and outcome

Emily F. Mason, Robert P. Hasserjian, Nidhi Aggarwal, Adam C. Seegmiller, Olga Pozdnyakova
Journal: Blood Advances
Blood Adv (2019) 3 (21): 3322–3332.
https://doi.org/10.1182/bloodadvances.2019000328
Published: 2019
Includes: Supplemental data
Journal Articles

A genomics-informed computational biology platform prospectively predicts treatment responses in AML and MDS patients

Clinical Trials & Observations
Leylah M. Drusbosky, Neeraj Kumar Singh, Kimberly E. Hawkins, Cesia Salan, Madeleine Turcotte, Elizabeth A. Wise, Amy Meacham, Vindhya Vijay, Glenda G. Anderson, Charlie C. Kim, Saumya Radhakrishnan, Yashaswini Ullal, Anay Talawdekar, Huzaifa Sikora, Prashant Nair, Arati Khanna-Gupta, Taher Abbasi, Shireen Vali, Subharup Guha, Nosha Farhadfar, Hemant S. Murthy, Biljana N. Horn, Helen L. Leather, Paul Castillo, Caitlin Tucker, Christina Cline, Leslie Pettiford, Jatinder K. Lamba, Jan S. Moreb, Randy A. Brown, Maxim Norkin, John W. Hiemenz, Jack W. Hsu, William B. Slayton, John R. Wingard, Christopher R. Cogle
Journal: Blood Advances
Blood Adv (2019) 3 (12): 1837–1847.
https://doi.org/10.1182/bloodadvances.2018028316
Published: 2019
Includes: Supplemental data
Journal Articles

Clinicopathologic and genetic characterization of nonacute NPM1 -mutated myeloid neoplasms

Clinical Trials & Observations
Sanjay S. Patel, Caleb Ho, Ryan N. Ptashkin, Sam Sadigh, Adam Bagg, Julia T. Geyer, Mina L. Xu, Thomas Prebet, Emily F. Mason, Adam C. Seegmiller, Elizabeth A. Morgan, David P. Steensma, Eric S. Winer, Waihay J. Wong, Robert P. Hasserjian, Olga K. Weinberg
Journal: Blood Advances
Blood Adv (2019) 3 (9): 1540–1545.
https://doi.org/10.1182/bloodadvances.2019000090
Published: 2019
Journal Articles

Impact of genomic alterations on outcomes in myelofibrosis patients undergoing JAK1/2 inhibitor therapy

Clinical Trials & Observations
Jay Y. Spiegel, Caroline McNamara, James A. Kennedy, Tony Panzarella, Andrea Arruda, Tracy Stockley, Mahadeo Sukhai, Mariam Thomas, Justyna Bartoszko, Jenny Ho, Nancy Siddiq, Dawn Maze, Aaron Schimmer, Andre Schuh, Hassan Sibai, Karen Yee, Jamie Claudio, Rebecca Devlin, Mark D. Minden, Suzanne Kamel-Reid, Vikas Gupta
Journal: Blood Advances
Blood Adv (2017) 1 (20): 1729–1738.
https://doi.org/10.1182/bloodadvances.2017009530
Published: 2017
Includes: Supplemental data
Journal Articles

Mutational analysis of disease relapse in patients allografted for acute myeloid leukemia

Lynn Quek, Paul Ferguson, Marlen Metzner, Ikhlaaq Ahmed, Alison Kennedy, Catherine Garnett, Sally Jeffries, Claudia Walter, Kim Piechocki, Adele Timbs, Robert Danby, Manoj Raghavan, Andrew Peniket, Mike Griffiths, Andrew Bacon, Janice Ward, Keith Wheatley, Paresh Vyas, Charles Craddock
Journal: Blood Advances
Blood Adv (2016) 1 (3): 193–204.
https://doi.org/10.1182/bloodadvances.2016000760
Published: 2016
Includes: Supplemental data